CP
CVS icon

CenterBook Partners’s CVS Health CVS Stock Holding History

CenterBook Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-210,370
Closed -$9.44M – 504
2024
Q4 		$9.44M Sell
210,370
-45,859
-18% -$2.57M 0.56% 39
2024
Q3 		$16.1M Buy
256,229
+124,945
+95% +$7.29M 0.99% 19
2024
Q2 		$7.75M Buy
131,284
+44,695
+52% +$2.8M 0.48% 52
2024
Q1 		$6.91M Sell
86,589
-86,835
-50% -$6.63M 0.48% 56
2023
Q4 		$13.7M Buy
173,424
+155,689
+878% +$11.1M 1.67% 3
2023
Q3 		$1.24M Sell
17,735
-802
-4% -$56.8K 0.15% 215
2023
Q2 		$1.28M Sell
18,537
-2,757
-13% -$196K 0.16% 213
2023
Q1 		$1.58M Buy
21,294
+2,689
+14% +$225K 0.22% 152
2022
Q4 		$1.73M Buy
18,605
+8,291
+80% +$800K 0.29% 125
2022
Q3 		$984K Buy
+10,314
New +$1.02M 0.19% 180

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

CenterBook Partners's CVS Position: Q1 2025 in Review

CenterBook Partners sold out of CVS Health (CVS) in Q1 2025, closing a stake of 210,370 shares — an estimated $9.44M sold.

CenterBook Partners first reported a position in CVS in Q3 2022 and held it in 10 quarters. The position peaked at $16.1M in Q3 2024. 1,756 funds tracked by Wall St. Rank hold CVS as of Q1 2025.

  • CenterBook Partners reported no remaining CVS Health position as of Q1 2025 after selling out during the quarter.
  • CenterBook Partners sold 210,370 CVS Health shares in Q1 2025, an estimated $9.44M.
  • CenterBook Partners first reported a position in CVS Health in Q3 2022 and held it in 10 quarters.
  • CenterBook Partners's CVS Health position peaked at $16.1M in Q3 2024.
  • 1,756 funds tracked by Wall St. Rank held CVS Health as of Q1 2025.

Based on CenterBook Partners's 13F filing for Q1 2025, filed 9 May 2025.